The impact of COVID-19 on respiratory tract microbiota pattern in patients with severe pneumonia
- Authors: Zolotov M.O.1, Kozlov A.V.1, Shafigullina L.R.1, Lyamin A.V.1
-
Affiliations:
- Samara State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 15, No 6 (2025)
- Pages: 1191-1196
- Section: SHORT COMMUNICATIONS
- URL: https://ogarev-online.ru/2220-7619/article/view/380255
- DOI: https://doi.org/10.15789/2220-7619-TIO-17903
- ID: 380255
Cite item
Full Text
Abstract
COVID-19 weakens the body’s immune system and predisposes to bacterial infections. It has been increasingly evident about changes in the etiological pattern of pneumonia pathogens due to altered lung microbiota after viral pneumonia, the effect of SARS-CoV-2 on the immune system, and antibiotics taking as part of preventing secondary bacterial infection. Our study was aimed to analyze the dynamic change in the pattern of the respiratory tract microbiota in patients with severe pneumonia in the years from 2019 to 2023. There were enrolled 304 patients with pneumonia diagnosed after X-ray examination assessed from January 2019 to December 2023 inclusive. During the pandemic, all the investigated patients had a positive SARS-CoV-2 PCR result, and in the period after the pandemic all the examined patients were negative. Sputum samples delivered to the laboratory, where we performed microbiological culture with identification by MALDI-ToF mass spectrometry. In the pre-COVID-19 pandemic, 62 sputum samples were analyzed, among which Klebsiella pneumoniae and Stenotrophomonas maltophilia were the most common found in 21% and 17.7%, respectively. Both Acinetobacter baumanii and Staphylococcus aureus were isolated in 14.5% cases. Streptococcus pneumoniae was found in 8.1% cases. During the COVID-19 pandemic, 122 samples were evaluated allowing to observe that K. pneumoniae accounted for half of all isolated microorganisms. The second most common was A. baumannii (23.8%). In the post-pandemic period, 120 samples were analyzed, from which K. pneumoniae was mainly identified (31.7%). The next most frequent among pathogens were S. aureus and A. baumannii — 23.3% and 18.3%, respectively. In this way, there was a statistically significant change in the frequency of detection of Gram-positive and Gram-negative microorganisms in ICU patients during the study periods. Before the COVID-19 pandemic, the proportion of Gram-negative microorganisms in the pattern of pathogens was 67.7%, during the pandemic — 91.0%, in the post-pandemic period — approached the values of 2019–2020 and amounted to 70.0% (p < 0.001). K. pneumoniae and A. baumannii were the most frequently found, however, the statistical significance of the changes was observed only for K. pneumoniae (p < 0.005). An insignificant decline in the detection rate of pneumococcus was established as well. The frequency of staphylococcal discharge after coronavirus infection exceeded the pre-pandemic magnitude (p < 0.001).
About the authors
M. O. Zolotov
Samara State Medical University of the Ministry of Health of the Russian Federation
Email: l.r.shafigullina@samsmu.ru
PhD (Medicine), Head of the Laboratory of Interdisciplinary Relations, Research and Educational Professional Center for Genetic and Laboratory Technologies
Russian Federation, SamaraA. V. Kozlov
Samara State Medical University of the Ministry of Health of the Russian Federation
Email: l.r.shafigullina@samsmu.ru
PhD (Medicine), Head of Laboratory of Molecular Pathology, Research and Educational Professional Center for Genetic and Laboratory Technologies
Russian Federation, SamaraLiliya R. Shafigullina
Samara State Medical University of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: l.r.shafigullina@samsmu.ru
Specialist of Laboratory of Molecular Pathology, Research and Educational Professional Center for Genetic and Laboratory Technologies
Russian Federation, SamaraA. V. Lyamin
Samara State Medical University of the Ministry of Health of the Russian Federation
Email: l.r.shafigullina@samsmu.ru
DSc (Medicine), Associate Professor, Director of Research and Educational Professional Center for Genetic and Laboratory Technologies
Russian Federation, SamaraReferences
- Авдеева М.Г., Кулбужева М.И., Зотов С.В., Журавлева Е.В., Яцукова А.В. Микробный пейзаж у госпитальных больных с новой коронавирусной инфекцией COVID-19, сравнительная антибиотикорезистентность с «доковидным» периодом: проспективное исследование // Кубанский научный медицинский вестник. 2021. Т. 28, № 5. С 14–28. [Avdeeva M.G., Kulbuzheva M.I., Zotov S.V., Zhuravleva Ye.V., Yatsukova A.V. Microbial landscape in hospital patients with new coronavirus disease (COVID-19), antibiotic resistance comparison vs. Pre-covid stage: a prospective study. Kubanskii naychnyi medicinskij vestnik = Kuban Scientific Medical Bulletin, 2021, vol 28, no. 5, pp. 14–28. (In Russ.)] doi: 10.25207/1608-6228-2021-28-5-14-28
- Иванова И.А., Омельченко Н.Д., Филиппенко А.В., Труфанова А.А., Носков А.К. Роль клеточного звена иммунитета в формировании иммунного ответа при коронавирусных инфекциях // Медицинская иммунология. 2021. Т. 23, № 6. С. 1229–1238. [Ivanova I.A., Omelchenko N.D., Filippenko A.V., Trufanova A.A., Noskov A.K. Role of the cellular immunity in the formation of the immune response in coronavirus infections. Meditsinskaya immunologiya = Medical Immunology (Russia), 2021, vol. 23, no. 6, pp. 1229–1238. (In Russ.)] doi: 10.15789/1563-0625-ROT-2302
- Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19): временные методические рекомендации. Версия 18 от 26.10.2023. [Prevention, diagnosis, and treatment of new coronavirus infection (COVID-19): temporary guidelines. Version 18 of 26.10.2023. (In Russ.)] URL: https://www.consultant.ru/document/cons_doc_LAW_347896
- Теплова Н.В., Ромашов О.М., Амелина Я.Г. Коронавирусная инфекция и бактериальная пневмония: актуальные акценты и курс на рациональную антибиотикотерапию // Лечебное дело. 2024. № 1. С. 8–14. [Teplova N.V., Romashov O.M., Amelina Ya.G. Coronavirus Infection and Bacterial Pneumonia: Current Emphases and a Course towards Rational Antibiotic Therapy. Lechebnoe delo = Lechebnoe delo, 2024, no. 1, pp. 8–14. (In Russ.)] doi: 10.24412/2071-5315-2024-13081
- Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, vol. 395, no. 10223, pp. 507–513. doi: 10.1016/S0140-6736(20)30211-7
- Chung Y.S., Lam C.Y., Tan P.H., Tsang H.F., Wong S.C. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies. Int. J. Mol. Sci., 2024, vol. 25, no. 15: 8155. doi: 10.3390/ijms25158155
- Fazel P., Sedighian H., Behzadi E., Kachuei R., Imani Fooladi A.A. Interaction Between SARS-CoV-2 and Pathogenic Bacteria. Curr. Microbiol., 2023, vol. 80, no. 7: 223. doi: 10.1007/s00284-023-03315-y
- Hespanhol V., Bárbara C. Pneumonia mortality, comorbidities matter? Pulmonology, 2020, vol. 26, no. 3, pp. 123–129. doi: 10.1016/j.pulmoe.2019.10.003
- Juan C.H., Fang S.Y., Chou C.H., Tsai T.Y., Lin Y.T. Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study. Antimicrob. Resist. Infect. Control, 2020, vol. 9, no. 1: 4. doi: 10.1186/s13756-019-0660-x
- Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J. Infect., 2020, vol. 81, no. 2, pp. 266–275. doi: 10.1016/j.jinf.2020.05.046
- Mirzaei R., Goodarzi P., Asadi M., Soltani A., Aljanabi H.A.A., Jeda A.S., Dashtbin S., Jalalifar S., Mohammadzadeh R., Teimoori A., Tari K., Salari M., Ghiasvand S., Kazemi S., Yousefimashouf R., Keyvani H., Karampoor S. Bacterial co-infections with SARS-CoV-2. IUBMB Life, 2020, vol. 72, no. 10, pp. 2097–2111. doi: 10.1002/iub.2356
- Principi N., Autore G., Ramundo G., Esposito S. Epidemiology of Respiratory Infections during the COVID-19 Pandemic. Viruses, 2023, vol. 15, no. 5: 1160. doi: 10.3390/v15051160
- Sulayyim H.J.A., Ismail R., Hamid A.A., Ghafar N.A. Antibiotic Resistance during COVID-19: A Systematic Review. Int. J. Environ. Res. Public Health, 2022, vol. 19, no. 19: 11931. doi: 10.3390/ijerph191911931
- Westblade L.F., Simon M.S., Satlin M.J. Bacterial Coinfections in Coronavirus Disease 2019. Trends Microbiol., 2021, vol. 29, no. 10, pp. 930–941. doi: 10.1016/j.tim.2021.03.018
Supplementary files

